Skip to content
AnalystLens

ALLSTATE CORP 8-K Report, Financial Results (Feb 5, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed February 5, 2025
Period End
February 5, 2025
In the record · 2016–202610-K1110-Q328-K240

ALL filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 240 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’16Nov ’16
  2. Deal closed8-K · Jan ’21Jan ’21
  3. Leadership change8-K · Aug ’22Aug ’22
  4. Leadership change8-K · Jul ’26Jul ’26

Summary

Summary of the 8-K filed February 5, 2025. Cited figures are marked; the original filing is the authoritative source.

Allstate reported a strong fourth quarter and full year 2024.

Q4 consolidated revenues rose 11.3% to $16.5 billiona, and net income applicable to common shareholders climbed 30.1% to $1.9 billion. Adjusted net income was $2.1 billion, or $7.67 per diluted share, up 31.8% from the prior year quarter. For full year 2024, net income applicable to common shareholders was $4.55 billion ($16.99 per diluted share) versus a loss in 2023, and adjusted net income was $4.9 billion, producing an adjusted return on equity of 26.8%.

The improvement was driven primarily by Property-Liability underwriting, where the Q4 recorded combined ratio improved 2.6 points to 86.9 and the full year ratio improved 10.2 points to 94.3. Allstate Protection auto results recovered meaningfully, with the auto combined ratio at 93.5 in Q4, while homeowners benefited from lower catastrophe losses in the quarter, though full-year catastrophe losses of $4.96 billionb remained significant. Management also highlighted portfolio and strategic developments.

Net investment income rose 34.3% in Q4 to $833 millionc, reflecting repositioning into higher-yielding fixed income, portfolio growth, and stronger performance-based returns. Unrealized net capital losses of $1.0 billion pre-tax at year-end, however, reflect rising interest rates. Strategically, Allstate agreed to sell Employer Voluntary Benefits and Group Health for a combined $3.25 billion, which is expected to generate a roughly $1.0 billion book gain in 2025.

Management indicated return on equity will be slightly lower after the sale, and the Individual Health business will either be retained or divested. The company also disclosed an estimated $1.1 billiond pre-tax net-of-reinsurance loss from the January 2025 California wildfires, a subsequent event that will weigh on first-quarter 2025 results.

For investors, the key takeaways are the sharp earnings recovery, the disciplined underwriting turnaround in auto and homeowners, and the capital redeployment enabled by the health business divestitures. The main watch items are catastrophe exposure as demonstrated by the California wildfire losses, the sustainability of auto rate increases and policy growth, and the effect of the health sales on the company's earnings base and return metrics.

Key Highlights

  1. Q4 2024 net income applicable to common shareholders of $1.9 billion (up 30.1%); diluted EPS $7.07 vs. $5.52 a year earlier
  2. Q4 adjusted net income of $2.1 billion, or $7.67 per diluted share, up 31.8% year over year
  3. FY 2024 adjusted net income of $4.9 billion and adjusted ROE of 26.8%, versus a $316 million loss applicable to common shareholders in 2023
  4. Property-Liability recorded combined ratio improved to 86.9 in Q4 (from 89.5) and 94.3 for FY 2024 (from 104.5), with auto and homeowners both improving
  5. Protection Services revenue rose 23.6% in Q4 to $889 million, led by Allstate Protection Plans and Arity
  6. Agreement to sell Employer Voluntary Benefits and Group Health for a combined $3.25 billion, with an expected roughly $1.0 billion book gain in 2025
  7. Estimated approximately $1.1 billion pre-tax net-of-reinsurance losses from the January 2025 California wildfires

Frequently Asked Questions

  1. What drove the improvement in Allstate's Property-Liability profitability in 2024?

    Higher average earned premiums from rate increases, improved underlying loss experience, and a lower expense ratio drove the improvement. The FY 2024 recorded combined ratio improved to 94.3 from 104.5, and the underlying combined ratio improved to 84.6 from 91.2. Auto rate increases contributed a 7.5% annualized premium impact in 2024.

  2. How significant is the sale of the Employer Voluntary Benefits and Group Health businesses?

    The combined $3.25 billion sale is expected to produce a roughly $1.0 billion book gain in 2025. Management said return on equity will be slightly lower after the sale, but the freed capital can support growth. The businesses remain in net income until they close, and Group Health assets and liabilities will be classified as held for sale beginning in Q1 2025.

  3. What is the financial impact of the January 2025 California wildfires?

    Allstate estimates pre-tax losses of about $1.1 billion, net of reinsurance. The company attributes the manageable exposure to a decision to reduce its California homeowners market share beginning in 2007 and to a comprehensive reinsurance program. This loss is a subsequent event and will affect first-quarter 2025 results.

  4. Is Allstate's investment portfolio performing well given the rate environment?

    Net investment income rose 34.3% in Q4 2024 to $833 million, helped by higher-yielding fixed income purchases and stronger performance-based returns. However, the total return on the portfolio was (1.1)% in Q4 because rising rates reduced fixed income valuations, leaving $1.0 billion of unrealized net capital losses at year-end. The full-year total return was 3.8%.

  5. What are the main risks investors should watch from this report?

    Key risks include catastrophe exposure, with full-year 2024 catastrophe losses of $4.96 billion and the January wildfire losses; the durability of auto margins as rate increases moderate; sensitivity of the investment portfolio to interest rates and performance-based volatility; and the earnings and return effects of the health business divestitures, including the unresolved status of the Individual Health business.